Black Hawk Acquisition (BKHA) vs Instil Bio (TIL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Black Hawk Acquisition is the larger company by market cap ($51.3 million vs $44.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | BKHA | TIL |
|---|---|---|
| Share price | $12.35 | $6.60 |
| Market cap | $51.30M | $44.76M |
| 1-day change | -5.00% | -3.65% |
| YTD return | — | -37.27% |
| 1-year return | — | -62.86% |
| 5-year return | — | -98.07% |
| P/E ratio (TTM) | 37.42 | — |
| EPS (TTM) | $0.33 | $-4.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.15 | $21.98 |
| 52-week low | $11.00 | $5.67 |
| Distance from 52-week high | -6.08% | -69.97% |
| Average volume | 3.63K | 11.93K |
| Shares outstanding | 4.15M | 6.78M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
BKHA vs TIL FAQ
Which is bigger, Black Hawk Acquisition or Instil Bio?
Black Hawk Acquisition (BKHA) is larger, with a market capitalization of $51.30M compared with $44.76M for Instil Bio (TIL).
Are Black Hawk Acquisition and Instil Bio in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.